Findings from a study exploring how AI-driven NCCN guideline interpretation can optimize genetic testing and reduce clinician burden in prostate cancer.
David M. Waterhouse, MD, MPH
Advertisement
Articles by David M. Waterhouse, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tocilizumab Supports Outpatient Bispecific Antibody Use in Multiple Myeloma
2
Perioperative Apalutamide Shifts Standard in Localized, High-Risk Prostate Cancer
3
ASCENT-04 Subgroup Analysis Yields Consistent PFS Benefits in Metastatic TNBC
4
Adjuvant Atezolizumab Shows Minimal Impact on Functioning/QOL in MIBC
5